Searching for a specific course? 


Use quotation marks to search only exact matches:
ETHICS FOR PROFESSIONALS brings up courses with any of those words in the description.
"ETHICS FOR PROFESSIONALS" looks for that exact word order.

Does your board use Precheck?  Click a link below to find your CE list

Alabama   Arizona   Georgia
New Mexico   Oklahoma   Texas


CBD and Phytocannabinoids: What You Need to Know

  • Board Restrictions note: Co-sponsored courses may not be eligible for CE in Tennessee; Credit calculations may vary for New Mexico approval
  • Event date: 1/15/2020 6:00 PM - 9:00 PM Export event

    Cannabidiol (CBD) is a phytocannabinoid; a chemical constituent sourced from plants in the cannabis genus. Other phytocannabinoids include tetrahydrocannabinol (THC), cannabinol, cannabigerol, and cannabichromene. Because THC is an hallucinogenic, cannabis cultivation has been banned in the United States for a century. Recent biopharma developments in medical CBD, along with passage of federal and state regulations supporting hemp research, has spurred interest in CBD. As a topical, CBD has therapeutic properties as an anti-inflammatory, anti-nociceptive, and anti-oxidant. There are potential risks, benefits, and legal implications for healthcare professionals who are interested in using topical CBD products with clients. This workshop will introduce the endocannabinoid system, examine CBD physiology, explore factors affecting development of and access to cannabis products, compare and contrast phytocannabinoids, and summarize legal and scope-of-practice issues influencing use of topical CBD.

    Workshop Objectives:

    At the end of this workshop, attendees will be able to:

    • Describe the endocannabinoid system
    • Differentiate between endocannabinoids and phytocannabinoids
    • Identify the plants in the cannabis genus and species
    • Recognize the influence of historical politics on cannabis in the United States
    • Compare and contrast clinical applications of CBD and THC
    • Summarize recent research on phytocannabinoids
    • Describe factors that influence availability of topical CBD and phytocannabinoids  products
    • State resources that govern scope of practice for professional use of topical phytocannabinoids
    • Explain third party verification and its relevance to plant-based products
    • List resources to monitor changes in legal use of topical CBD in professional practice
    InstructorVirginia S. Cowen, PhD
    About the Instructor Virginia S. Cowen, PhD is a consultant for clients in the consumer cannabis industry, and has developed graduate level Ethnomedicine and Natural Therapies curriculum and business sector workshops on The Endocannabinoid System. Dr. Cowen is also a therapeutic massage, bodywork and exercise professional with years of experience teaching and developing health curriculum at the college and post-graduate levels.
    Subject Breakdown Introductions and Agenda Overview of the Endocannabinoid System · Discovery · Anatomy & physiology · Endocannabinoids •anandamide •2-arachidonoylglycerol · Fatty acid amide hydrolase (FAAH) inhibitors · Clinical implications Cannabis · Marihuana, marijuana, and hemp botanical summary · History of cannabis in the U.S. Phytocannabinoids and endocannabinoids · CBD · THC · Other cannabinoids Research on phytocannabinoids · Medical CBD · Medical cannabis · CBD for wellness and consumer use · Challenges in cannabis research Legal Implications for topical use · The 2018 Agriculture Improvement Act · State regulations · The importance of third party verification · Professional scope of practice
    Total Credits3.00
    FormatIn person - Live
    Institute for Continuing Education

    Institute for Continuing Education Institute for Continuing Education

    Other posts by Institute for Continuing Education

    Contact author

    Contact author


    Upcoming events